68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
FAPI is a fibroblast activation protein inhibitor and 68Ga-FAPI-04 is a potential new imaging
agent for imaging of carcinoma. 68Ga-FAPI-04 PET/CT is helpful to clarify the benign,
malignant and invasive range of the oral carcinoma, locate and qualitatively diagnose the
tumor, and make early diagnosis and restaging of recurrent tumor.